Local Services

Community Pharmacy Contractors are providing a range of additional services many of which are pertinent to the needs of their local Health Board.

NHS Boards negotiate locally with Community Pharmacy Health Board Committees on remuneration for the following pharmaceutical services

  • Advice to Residential Homes
  • Dispensing of Methadone for Drug Users
  • Needle Exchange Services
  • Disposal of Patients’ Unwanted Medicines
  • Out of Hours rotas
  • Collection and delivery services

Advice to Residential Homes 

Advice to Residential HomesGood practice guidance section 1 for this service was completed by the Scottish Chief Pharmaceutical Officer’s group. Different service specifications and claim mechanisms may be present in each NHS Board. Contractors who wish to provide the service as they support the dispensing for a care home should speak to their local NHS Board.

Dispensing and/or supervision of Methadone for Drug Users

MethadoneGood practice guidance section 4 for this service was completed by the Scottish Chief Pharmaceutical Officer’s group. Different service specifications and claim mechanisms may be present in each NHS Board. Contractors who wish to provide the service should speak to their local NHS Board.

Needle Exchange

Needle ExchangeGood practice guidance section 4 for this service was completed by the Scottish Chief Pharmaceutical Officer’s group. Different service specifications and claim mechanisms may be present in each NHS Board. Contractors who wish to provide the service should speak to their local NHS Board.

 

Disposal of Unwanted Medicines

Unwanted MedicinesNHS Boards are required by the Scottish Government to provide a service whereby patients are able to return unwanted medicines to their community pharmacy. Once collected the Health Board is responsible for ensuring its collection and disposal by incineration.

Changes in waste legislation have occurred over the last few years and contractors may contact their Health Board for advice on the safe disposal of unwanted medicines. The original good practice guidance prepared by the Scottish Chief Pharmaceutical Officer’s group may have been superseded in part by changes in legislation.